MTI 100: Separations, Value Creation And Innovation Top The Agenda For Healthtechs

Portfolio Optimization Set To Remain In Vogue

 
• By Ashley Yeo
  
Business leaders ready to eschew low-growth activity (Shutterstock)

More from Business

More from Medtech Insight